How Will Sorrento Therapeutics Deal With the Added COVID-19 Competition?

In this video from Motley Fool Live recorded on Nov. 12, executives from Sorrento Therapeutics (NASDAQ: SRNE) talk about how the company's COVID-19 therapeutic antibodies -- STI-1499 and STI-2020 -- can coexist with the coronavirus vaccines.

Since the recording, both Moderna (NASDAQ: MRNA) and the duo of Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) have reported data showing their vaccines can reduce the likelihood of severe cases of COVID-19 compared to placebo.

Continue reading

Source Fool.com